On April 13, the U.S. intervened in five lawsuits against Insys Therapeutics Inc., which all accuse the company of violating the False Claims Act in regard to its opioid painkiller, Subsys. The painkiller is a sublingual spray form of fentanyl, an extremely potent and addictive drug.
Fentanyl has made the news in recent years as a replacement for heroin and other illegal street drugs, which has led to an increase in drug overdoses. Fentanyl analogues are hundreds of times more potent than heroin, and thousands of times stronger than morphine. Considering the risk of addiction and dependence on opioid painkillers, and the risk of death, the government takes accusations of improper marketing and prescribing of the drug seriously.
If you are aware of illegal activity regarding opioid drugs at a doctor’s office or medical facility, contact an experienced San Francisco health care fraud lawyer at Brod Law Firm today. Not only may the activity be a crime under California or federal law, it may also give rise to a civil claim.
Healthcare Fraud Lawyer Blog



Alere, Inc. and its wholly owned subsidiary Alere San Diego agreed to pay the U.S. $33.2 million to resolve allegations that the medical device manufacturer
In March, the Department of Justice for the Eastern District of California announced the federal government and California reached a
In mid-April, Aharon Aron Krkasharyan, 54, a former employee of Mauran Ambulance Inc. (Mauran) of San Fernando, was sentenced for his part in a
In April 2018, the U.S. Attorney’s Office for the Southern District of California announced that two physicians pled guilty to participating in a
In early April, two executives for a business offering alcohol and drug abuse treatment services were
California lawmakers are concerned with health care providers who may be taking advantage of patients by unnecessarily enrolling them into commercial health care plans in order to
On March 8, the Riverside County District Attorney announced that four men had been arrested in connection with an $8 million
The U.S. Department of Justice (DOJ) announced mid-March that a dentist based in Los Angeles has been charged with conducting an